Skip to content
OpenCapital
Get started

Precigen PGEN Increase (decrease) in contract liabilities and current deferred income

Increase (decrease) in contract liabilities and current deferred income at other companies

ALN
Alnylam PharmaceuticalsALNY
——

Other financials

Income statement

See full
Revenue$23.3M+1,634%
Operating income-$6.0M+73.5%
Net income-$7.9M+85.4%
EPS (diluted)-$0.02+88.9%

Balance sheet

See full
Cash & equivalents$7.5M+23.5%
Total debt$98.3M+1,714%
Total equity$20.2M+244%
Total assets$138.6M+7.6%

Cash flow

See full
Operating cash flow-$43.8M-168%
CapEx$258.0K-58.5%
Free cash flow-$44.1M-160%

Valuation

See full
Market cap$1.93B+213%
Enterprise value$2.02B+234%
P/S72.5×—

Profitability

See full
Gross margin83.6%—
Operating margin-2,890.9%—
Net margin-3,656%—
FCF margin-1,756.5%—

Returns & leverage

See full
Return on equity-843.6%-1,103pp
Debt / equity4.9×—
Current ratio4.8×+1.3×

Where this comes from

Reported directly by Precigen in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInContractWithCustomerLiability.

The official record: Precigen’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Precigen's increase (decrease) in contract liabilities and current deferred income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Precigen's increase (decrease) in contract liabilities and current deferred income?
Precigen (PGEN) reported increase (decrease) in contract liabilities and current deferred income of -$107K in Q1 2026.
How has Precigen's increase (decrease) in contract liabilities and current deferred income changed year-over-year?
Precigen's increase (decrease) in contract liabilities and current deferred income increased by 22.5% year-over-year, from -$138K to -$107K.
What is the long-term trend for Precigen's increase (decrease) in contract liabilities and current deferred income?
Over 3 years (2022 to 2025), Precigen's increase (decrease) in contract liabilities and current deferred income has grown at a -55.9% compound annual growth rate (CAGR), from -$23.4M to -$2.01M.